<DOC>
	<DOCNO>NCT00421863</DOCNO>
	<brief_summary>Multicenter , prospective , randomise , open study compare effect follow two strategy hypertensive subject &gt; 55 year poorly control ( systolic blood pressure &gt; = 150 mmHg ) antihypertensive treatment : - usual strategy : reduction systolic blood pressure 140 mmHg , independently diastolic blood pressure level ; - intensive strategy : reduction systolic blood pressure 130 mmHg , independently diastolic blood pressure level . During initial run period two qualify visit distance 7-14 day carry establish whether blood pressure remain uncontrolled ( systolic blood pressure &gt; =150 mmHg ) current drug treatment . At end second visit eligible patient admit study follow examination carry : clinical visit , routine laboratory test , 12-lead ECG . At point eligible patient randomise one two blood pressure goal outline . Subsequent clinical visit carry 4 month-intervals end study ( 4 , 8 , 12 , 16 , 20 , 24 month ) .</brief_summary>
	<brief_title>Italian Study Cardiovascular Effects Systolic Blood Pressure Control - CARDIOSIS Study</brief_title>
	<detailed_description>Study partially sponsor : Boehringer Ingelheim , Sanofi-Aventis , Pfizer</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<criteria>write informed consent study age &gt; = 55 year randomization . There upper age limit systolic blood pressure &gt; = 150 mmHg 2 visit distance 714 day , irrespective diastolic pressure . Duration treatment visit 1 must least 12 week least one additional risk factor include follow : current cigarette smoking total cholesterol &gt; = 20 mmg/dl , High Density Lipoproteins ( HDL ) &lt; 40 mg/dl , Low Density Lipoproteins ( LDL ) cholesterol &gt; = 130 mg/dl family history cardiovascular disease male first degree relative &lt; 55 year female first degree relative &lt; 65 year previous TIA stroke previous coronary artery disease history peripheral occlusive arterial disease ( claudication intermittens associate angiographic echographic evidence &gt; 60 % stenosis ) diabetes ( fast glucose &gt; 125 mg/dl two sample ongoing diabetic treatment ) renal failure , define serum creatinine &gt; 2.0 mg/dl chronic atrial fibrillation flutter clinically significant hepatic hematological disorder , alcoholism , drug addiction cause preclude ECG interpretation LVH : complete right leave bundle block , WolffParkinsonWhite syndrome , previous Qwave myocardial infarction disease causing reduce life expectancy unwilling participate significant ( trace ) valvular heart disease</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>hypertension</keyword>
	<keyword>systolic blood pressure</keyword>
</DOC>